Salusins: Potential Use as a Biomarker for Atherosclerotic Cardiovascular Diseases
Human salusin-α and salusin-β are related peptides produced from prosalusin. Bolus injection of salusin-β into rats induces more profound hypotension and bradycardia than salusin-α. Central administration of salusin-β increases blood pressure via release of norepinephrine and arginine-vasopressin. C...
Saved in:
| Main Authors: | Kengo Sato, Rena Watanabe, Fumiko Itoh, Masayoshi Shichiri, Takuya Watanabe |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2013-01-01
|
| Series: | International Journal of Hypertension |
| Online Access: | http://dx.doi.org/10.1155/2013/965140 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Salusin beta, atherosclerosis, and coronary slow flow
by: Sinan Akıncı, et al.
Published: (2020-01-01) -
Present and Future Perspectives on the Role of Biomarkers in Atherosclerotic Cardiovascular Disease Risk Stratification
by: Bruna Gigante
Published: (2023-04-01) -
Measurement of salusin-ß without the addition of NP-40 or Tween-20 in coronary slow-flow phenomenon
by: Suna Aydin, et al.
Published: (2019-12-01) -
Non-traditional lipid biomarkers in atherosclerotic cardiovascular disease: pathophysiological mechanisms and strategies to address residual risk
by: Cong Wang, et al.
Published: (2025-07-01) -
Remnant Cholesterol and Residual Risk of Atherosclerotic Cardiovascular Disease
by: Xi Li, et al.
Published: (2025-02-01)